EVOLUTION OF IV IRON COMPOUNDS OVER THE LAST CENTURY
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
SUMMARY: Administration of intravenous (IV) iron has become pivotal in the management of anaemia in patients with chronic kidney disease (CKD). Since parenteral iron was first introduced for human use in the 1930s, things have come a long way. Seventy years ago, iron was toxic, administered as an iron oxyhydroxide complex. This problem was circumvented with the introduction of compounds containing iron in a core surrounded by a carbohydrate shell. The carbohydrate shell consists of molecules such as dextran, sucrose, dextrin or gluconate. The first dextran‐containing IV iron preparations carried a small risk of anaphylaxis, but the more recently introduced low molecular weight iron dextran preparation has significantly less risk of this. Iron reactions occur with all IV iron preparations, but are generally not thought to be immune based. Recently, newer IV iron preparations have appeared in the market, including Ferumoxytol (Feraheme®) and ferric carboxymaltose (Ferinject®). These latest IV iron preparations do not contain a requirement for a test dose, and a much higher dose of iron can be delivered as a single administration. Thus, giving supplemental iron to man has come a long way since 1930s; we are now in an era when we are able to administer higher doses of iron with acceptable safety and without significant adverse effects. However, the long‐term safety of the newer IV iron preparations is not yet established.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Weiss, G., & Goodnough, L. T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041809 · Cited by 3,800
Cited by
Anselmo, A. C., & Mitragotri, S. (2016) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10003 · Cited by 1,321
“These nanoparticle approaches originated from the need to address toxicity issues associated with the injection of free iron.(40,42) Using colloidal iron coated with sugars, many of these toxicity issues were resolved.”
BackgroundIron considerations for the athlete: a narrative review
Sim, M., Garvican-Lewis, L. A., Cox, G. R., Govus, A., McKay, A. K. A., Stellingwerff, T., & Peeling, P. (2019) · European Journal of Applied Physiology · doi:10.1007/s00421-019-04157-y · Cited by 274
“Modern advances in IV preparations (Macdougall, 2009) have increased the safety and accessibility of IV supplementation, with injections or infusions commonly delivered in an outpatient setting.”
BackgroundJahn, M. R., Andreasen, H. B., Fütterer, S., Nawroth, T., Schünemann, V., Kolb, U., Hofmeister, W., Muñoz, M., Bock, K., Meldal, M., et al. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.03.016 · Cited by 256
“This problem was circumvented with the introduction of compounds containing iron in a core surrounded by a carbohydrate shell [9].”
BackgroundInfluentialIntravenous iron supplementation in distance runners with low or suboptimal ferritin
GARVICAN, L. A., SAUNDERS, P. U., CARDOSO, T., MACDOUGALL, I. C., LOBIGS, L. M., FAZAKERLEY, R., FALLON, K. E., ANDERSON, B., ANSON, J. M., THOMPSON, K. G., et al. (2014) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e3182a53594 · Cited by 91
Self-citationIron Deficiency in Adolescent and Young Adult German Athletes—A Retrospective Study
Roy, R., Kück, M., Radziwolek, L., & Kerling, A. (2022) · Nutrients · doi:10.3390/nu14214511 · Cited by 41
Metadata
- Authors
- Macdougall, I. C.
- Venue
- Journal of Renal Care
- Publisher
- Wiley
- Published
- 2009-11-03
- Volume
- 35
- Issue
- s2
- Pages
- 8-13
- ISSN
- 1755-6678 (ISSN-L)
- 1755-6686
- OpenAlex
- W1981144176
- Cited by
- 60
- References
- 1
- FWCI
- 3.37
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: EVOLUTION OF IV IRON COMPOUNDS OVER THE LAST CENTURY. https://app.cochat.ai/papers/10.1111/j.1755-6686.2009.00127.x
- The paper
- Macdougall, I. C. (2009). EVOLUTION OF IV IRON COMPOUNDS OVER THE LAST CENTURY. Journal of Renal Care. https://doi.org/10.1111/j.1755-6686.2009.00127.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.